CoChat

Chromium Supplementation Does Not Improve Glucose Tolerance, Insulin Sensitivity, or Lipid Profile

Gunton, Jenny E., Cheung, N. Wah, Hitchman, Rosemary, Hams, Graham, O’Sullivan, Christine, Foster-Powell, Kaye, McElduff, Aidan · 2005 · Diabetes Care
Cited by 73

The DOI matches its Crossref record.

Abstract

Chromium supplements are thought to be the second most commonly taken nutritional supplement, used by an estimated 10 million Americans (1). Chromium is an essential element in humans, and deficiency is associated with the development of diabetes, which was first noted in patients receiving long-term parenteral nutrition before the advent of routine chromium supplementation (2,3). In these patients, diabetes resolved following chromium replacement (2–4). The dietary requirement for chromium is controversial, with the recommended daily intake in the U.S. being 0.05–0.20 μg (5). Chromium is abundant in the environment; however, aside from the extreme situation of unsupplemented parenteral nutrition, it has proven difficult to ascertain any clinical effects, due solely to chromium deficiency. Despite these difficulties, chromium supplements are widely promoted in the complementary health industries. There are many studies examining the effects of various forms of chromium supplementation (rev. in 6,7). These studies utilized a variety of chromium formulations, varying doses, and patients with normal glucose tolerance, diabetes, or gestational diabetes. The outcomes have been inconsistent. Some studies showed no benefit, and other studies have shown inconsistent improvements in glucose, insulin resistance, and/or lipids. The paucity of data has prompted the National Institutes of Health to release a program announcement to address the issue: “Chromium as an adjuvant therapy …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diacare.28.3.712

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 73

Metadata

Authors
Gunton, J. E., Cheung, N. W., Hitchman, R., Hams, G., O’Sullivan, C., Foster-Powell, K., & McElduff, A.
Venue
Diabetes Care
Published
2005-03-01
Volume
28
Issue
3
Pages
712-713
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W1992852598
Cited by
73
References
0
FWCI
6.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chromium Supplementation Does Not Improve Glucose Tolerance, Insulin Sensitivity, or Lipid Profile. https://app.cochat.ai/papers/10.2337/diacare.28.3.712
The paper
Gunton, J. E., Cheung, N. W., Hitchman, R., Hams, G., O’Sullivan, C., Foster-Powell, K., & McElduff, A. (2005). Chromium Supplementation Does Not Improve Glucose Tolerance, Insulin Sensitivity, or Lipid Profile. Diabetes Care. https://doi.org/10.2337/diacare.28.3.712

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.